SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received clearance ...
Credit: Getty Images. The intent of the document is to help reduce heparin product overdose errors caused by misinterpretation of the drug strength displayed in the labeling. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results